Market Insight

Avulux, a Florida-based company, has received de novo marketing authorization from the FDA for its precision optical lenses designed to manage light sensitivity associated with migraine, becoming the first product of its kind to receive the designation. The lenses are indicated for patients aged 12

Medtronic is the largest medical device company in the world, and it rarely goes a month without an exciting advancement: a tuck-in acquisition, a new FDA clearance, a leadership change, or a shift in strategy. For anyone hiring into the MedTech space, competing against Medtronic, or trying to keep

Virtual Incision Corporation has received FDA 510(k) clearance to use its MIRA Surgical System in benign hysterectomy procedures, expanding the platform beyond its original colectomy indication. MIRA, headquartered in Lincoln, Nebraska, became the world's first miniaturized robotic-assisted surgery

MaxQ Medical, a health-tech company based in Sunnyvale, California, has closed a $31.5 million Series A financing round led by Olympus Innovation Ventures, Atlantic Blue Ventures, and S3 Ventures, with continued participation from existing investor Hillside Capital. The round marks the first spinout

Shape Memory Medical has secured $10 million in convertible note financing led by August Global Partners, with new investor Taiwania Capital and support from HEAL Venture Lab. The Santa Clara-based company will use the funds for patient follow-up and data collection in its AAA-SHAPE Pivotal Trial, a

Siemens Healthineers has secured a federal award of up to $31.1 million over five years from ARPA-H to develop autonomous, remote endovascular robotics for treating acute ischemic stroke via mechanical thrombectomy, a procedure the company aims to eventually perform with no direct human operator inv

From smart-ring diagnostics and AI-native MSK care to pediatric cardiac devices and prostate-focused imaging, this week's MedTech funding highlights investor confidence in platforms that extend clinical monitoring beyond the hospital and into earlier, more targeted intervention.

As an executive sea

Renata Medical has closed a $25 million Series D funding round to accelerate the global rollout and pipeline development of its paediatric stent technology. The round was led by private equity firm Archimed, with existing investors also participating. The California-based company's flagship product,

Masimo has received CE Mark approval for smartSedLine, its next-generation brain function monitor designed to improve intraoperative anesthesia management. The key innovation is an AI-powered Patient State Index (PSi) algorithm, which continuously processes bilateral frontal EEG data and translates